<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

LSX Nordic Congress-1


 29-30 AUGUST 2018 | NASDAQ OFFICE | STOCKHOLM

DOWNLOAD THE BROCHURE
BOOK YOUR TICKET NOW

2018 Event Partners

ABOUT THE LSX Nordic Congress


The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalisation.

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we will bring together the people that matter to the future of life sciences in the Nordic region to address these challenges and work towards actionable outcomes to help it flourish.

LEARN MORE

SATELLITE AND ANCILLARY FORUMS

                     LSX Nordic Final.png                           CEO Forum-2.png                              Investable-4.png                     IPO Bootcamp 2018.png

        VIEW THE ADVANCED BROCHURE FOR:

                                                          Provisional Agenda and Invited Speakers
                                                           Ancillary Forums and Events
                                                          Reasons To Attend
                                                          

DOWNLOAD THE BROCHURE

Nordic Congress Download Brochure.png

KEY SPEAKERS INCLUDE:

Søren Møller, Managing Partner, Novo Seeds

Søren Møller

Managing Partner
Novo Seeds
Mårten Steen, Partner, HealthCap

Mårten Steen

Partner
HealthCap
Miriam Frieden, Vice President R&D Innovation Sourcing, Novo Nordisk

Miriam Frieden

Vice President R&D Innovation Sourcing
Novo Nordisk
Sten Verland, Senior Partner, Sunstone Capital

Sten Verland

Senior Partner
Sunstone Capital
Mats Blom, CFO, Zealand Pharma

Mats Blom

CFO
Zealand Pharma
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Nina Rawal, Head of Life Science, Industrifonden

Nina Rawal

Head of Life Science
Industrifonden
ÅSA RIISBERG Partner and Head of Healthcare Sector EQT PARTNERS

ÅSA RIISBERG

Partner and Head of Healthcare Sector
EQT PARTNERS
JONAS HANSSON CEO WILSON THERAPEUTICS

JONAS HANSSON

CEO
WILSON THERAPEUTICS
CHRISTINE LIND President & CEO MEDIVIR AB

CHRISTINE LIND

President & CEO
MEDIVIR AB
DON DEBETHIZY Chairman SANIONA

DON DEBETHIZY

Chairman
SANIONA
JENNI NORDBORG National Coordinator Life Sciences GOVERNMENT OFFICES OF SWEDEN

JENNI NORDBORG

National Coordinator Life Sciences
GOVERNMENT OFFICES OF SWEDEN
VIEW ALL SPEAKERS

OFFICIAL EVENT PARTNER

Nasdaq17_313+BK.png                 

 PREVIOUS NORDIC CLIENTS AND PARTNERS

Investors LSX Nordic

2018 EVENT VENUE

Address: 

Nasdaq Stockholm
Tullvaktsvägen 15, 105 78 Stockholm, Sweden

CONTACT US

Address : Suite 132, The Business Design Centre, 52 Upper St, London, N1 0QH, UK

Email: info@biotechandmoney.com

Phone: +44 (0) 203 637 5908